Neonatal Abstinence Syndrome Clinical Trial
Official title:
A Comparison of Mismatch Negativity Waveform Differences in Opioid-exposed and Non-exposed Neonates.
The purpose of this study is to identify problems with interpreting sounds in babies that have been exposed to opioids prior to birth. Being able to identify these issues in infancy may allow us to find children who may have problems with language learning later in life so that we can try to minimize these.
This is a single center prospective study of neonates >36 weeks' gestation prenatally exposed to psychoactive substances and gestationally age-matched controls. Evoked response potentials on EEG in response to auditory oddball paradigms will be compared between cohorts. Analyses will try to identify differences in auditory processing using ANOVAs to compare the mismatch negativity measures, amplitudes and latencies as a function of study group. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01965704 -
Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women
|
Phase 2 | |
Completed |
NCT03890562 -
Assessing the Effects of Auricular Acupressure on Newborns With NAS
|
N/A | |
Completed |
NCT01958476 -
Improving Outcomes in Neonatal Abstinence Syndrome
|
Phase 3 | |
Active, not recruiting |
NCT01734551 -
NAS Treatment - Opiate Versus Non-Opiate
|
Phase 4 | |
Completed |
NCT00496951 -
Vagal Tone and Neonatal Abstinence Syndrome
|
N/A | |
Completed |
NCT02851303 -
Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome
|
Phase 4 | |
Recruiting |
NCT05226624 -
The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program
|
N/A | |
Completed |
NCT03670160 -
Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT04611659 -
Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine
|
N/A | |
Completed |
NCT01452789 -
Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome
|
Phase 3 | |
Completed |
NCT04588519 -
tAN to Mitigate Withdrawal Behaviors in Neonates
|
N/A | |
Completed |
NCT02797990 -
Conflict Between Maternal Autonomy and Child Health in Substance-use
|
N/A | |
Completed |
NCT02801331 -
Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence Syndrome
|
N/A | |
Terminated |
NCT03246243 -
Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk
|
||
Recruiting |
NCT06303986 -
Study to Collect Data for Neonatal Abstinence Syndrome (NAS) and Evaluate the Automated Data Collection Process
|
||
Active, not recruiting |
NCT03725332 -
The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural Kentucky
|
N/A | |
Recruiting |
NCT04983563 -
Actigraphy and Neonatal Abstinence Syndrome of Hospitalized Newborn in Intensive Care Units
|
N/A | |
Completed |
NCT04298853 -
Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
|
Phase 4 | |
Completed |
NCT02182973 -
Donor Human Milk in Neonatal Abstinence Syndrome
|
||
Completed |
NCT02810782 -
How to Treat Opiate Withdrawal in Neonates
|
Phase 3 |